✦ LIBER ✦

Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression

✍ Scribed by Miri Blank; Jacob George; Pnina Fishman; Yair Levy; Vladimir Toder; Shoshana Savion; Vivian Barak; Takao Koike; Yehuda Shoenfeld

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 868 KB
Volume: 41
Category: Article
ISSN: 0004-3591
DOI: 10.1002/1529-0131(199802)41:2<224::aid-art6>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Granulocyte—macrophage colony-stimulatin

Granulocyte—macrophage colony-stimulating factor treatment of neutropenia associated with Felty's syndrome

📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB 👁 2 views

Eosinophilia associated with adult t-cel

Eosinophilia associated with adult t-cell leukemia: Role of interleukin 5 and granulocyte-macrophage colony-stimulating factor

✍ Ogata, Masao; Ogata, Yuko; Kohno, Kazuhiro; Uno, Noritaka; Ohno, Eiji; Ohtsuka, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB 👁 2 views

To clarify the mechanism of eosinophilia in adult T-cell leukemia (ATL), we studied three ATL patients having marked eosinophilia. Eosinophil-predominant colony-stimulating activity was detected in the serum of one patient and in the conditioned media (CM) from cultured ATL cells from two patients.

Expression of the transforming growth fa

Expression of the transforming growth factor-α gene by human eosinophils is regulated by interleukin-3, interleukin-5, and granulocyte-macrophage colony-stimulating factor

✍ Marion A. Brach; Claudia Sott; Michael Kiehntopf; Friedhelm Herrmann 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 608 KB

Sequential interleukin 3 and granulocyte

Sequential interleukin 3 and granulocyte-macrophage–colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses

✍ Hillary H. Wu; Moshe Talpaz; Richard E. Champlin; Susan R. Pilat; Razelle Kurzro 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

## Background: Interleukin-3 (il-3) and granulocyte-macrophage-colony stimulating factor (gm-csf) have synergistic, hematopoietic growth-promoting activity in preclinical studies. because of the paucity of effective therapies for patients with chronic bone marrow failure states, the authors studied

Recombinant murine granulocyte-macrophag

Recombinant murine granulocyte-macrophage (GM) colony-stimulating factor supports formation of GM and multipotential blast cell colonies in culture: Comparison with the effects of interleukin-3

✍ Kenichi Koike; Makio Ogawa; James N. Ihle; Takaji Miyake; Tomoe Shimizu; Atsushi 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 808 KB

We studied the effects of murine recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) on murine hemopoiesis in methylcellulose culture. The GM-CSF was purified from cultures of Saccharomyces cerevisiae transfected with a cloned murine GM-CSF cDNA. In cultures of spleen cells from no

A Phase I study of granulocyte-macrophag

A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors : A report of the Children's Cancer Group

✍ Mitchell S. Cairo; Mark D. Krailo; Joel A. Weinthal; Rita Secola; Sharon Bergero 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 3 views

## Background: This phase i trial was developed to determine the safety, biologic activity, and effects on hematopoietic recovery of pixy321 following ifosfamide, carboplatin, and etoposide chemotherapy for children with recurrent or refractory solid tumors. ## Methods: Children (age < 22 years a